Accueil>>Signaling Pathways>> Membrane Transporter/Ion Channel>> Monoamine transporter>>Radafaxine hydrochloride (GW-353162A)

Radafaxine hydrochloride (GW-353162A) (Synonyms: BUPOH, BW 306U, GW 353162A, Radafaxine)

Catalog No.GC31060

Le chlorhydrate de radafaxine (GW-353162A) (GW-353162A) est un inhibiteur des transporteurs DAT (transporteur de la dopamine) et NET (transporteur de la noradrénaline) et un modulateur de la famille nAChR.

Products are for research use only. Not for human use. We do not sell to patients.

Radafaxine hydrochloride (GW-353162A) Chemical Structure

Cas No.: 106083-71-0

Taille Prix Stock Qté
10mM (in 1mL DMSO)
87,00 $US
En stock
5mg
78,00 $US
En stock
10mg
147,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Radafaxine Hcl(BW-306U; GW-353162A) is a potent metabolite of bupropion; selective for inhibiting the reuptake of norepinephrine over dopamine; DAT (dopamine transporter) and NET(norepinephrine transporter) transporters inhibitor, and nAChR family modulator.

[1]. Xu H, et al. Stereoselective analysis of hydroxybupropion and application to drug interaction studies. Chirality. 2007 Mar;19(3):163-70. [2]. Bondarev ML, et al. Behavioral and biochemical investigations of bupropion metabolites. Eur J Pharmacol. 2003 Aug 1;474(1):85-93.

Avis

Review for Radafaxine hydrochloride (GW-353162A)

Average Rating: 5 ★★★★★ (Based on Reviews and 6 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Radafaxine hydrochloride (GW-353162A)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.